Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

New therapies are being developed that target integrin pathways to treat various diseases.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Plasmatherapy improves immune status in vitiligo patients, especially those with segmental vitiligo.

Early diagnosis of hair tourniquet syndrome saved a baby's toe from being lost.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Red spots on fingertips can be a sign of a skin condition linked to gluten sensitivity, treatable with a gluten-free diet.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Ift20 is essential for hair follicle function and skin cell movement.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

PRP injections can effectively treat alopecia areata.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Combining PRP with follicular transplantation improves vitiligo treatment better than follicular transplantation alone.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.